Is it time to Buy before this week’s earning report NYSEAMERICAN:MAG, NASDAQ:ACTG, NASDAQ:SRAX, NASDAQ:PTPI

MAG SILVER (NYSEAMERICAN:MAG) EARNINGS INFORMATION (NYSEAMERICAN:MAG)

MAG Silver last released its earnings data on May 17th, 2021. The reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.00 by $0.04. MAG Silver has generated ($0.05) earnings per share over the last year. MAG Silver has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, August 11th, 2021 based off prior year’s report dates.

IS MAG SILVER A BUY RIGHT NOW? (NYSEAMERICAN:MAG)

7 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for MAG Silver in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” MAG Silver stock.
MAG Silver

ACACIA RESEARCH (NASDAQ:ACTG) EARNINGS INFORMATION (NASDAQ:ACTG)

Acacia Research last issued its earnings data on March 29th, 2021. The business services provider reported ($0.09) earnings per share (EPS) for the quarter. The business earned $4.38 million during the quarter. Acacia Research has generated $0.00 earnings per share over the last year and currently has a price-to-earnings ratio of 45.9. Acacia Research has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 9th, 2021 based off prior year’s report dates.

IS ACACIA RESEARCH A BUY RIGHT NOW? (NASDAQ:ACTG)

1 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Acacia Research in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Acacia Research stock.
Acacia Research

SRAX (NASDAQ:SRAX) EARNINGS INFORMATION (NASDAQ:SRAX)

SRAX last issued its quarterly earnings data on March 29th, 2021. The business services provider reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07). The firm earned $4.52 million during the quarter. SRAX has generated $0.00 earnings per share over the last year. SRAX has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 16th, 2021 based off prior year’s report dates.

IS SRAX A BUY RIGHT NOW? (NASDAQ:SRAX)

3 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for SRAX in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” SRAX stock.
SRAX

PETROS PHARMACEUTICALS EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:PTPI)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN PETROS PHARMACEUTICALS? (NASDAQ:PTPI)

Wall Street analysts have given Petros Pharmaceuticals a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Petros Pharmaceuticals wasn’t one of them. MarketBeat thinks these five companies may be even better buys.